143 related articles for article (PubMed ID: 9829839)
21. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
[TBL] [Abstract][Full Text] [Related]
22. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.
Chu JL; Ramos P; Rosendorff A; Nikolić-Zugić J; Lacy E; Matsuzawa A; Elkon KB
J Exp Med; 1995 Jan; 181(1):393-8. PubMed ID: 7528774
[TBL] [Abstract][Full Text] [Related]
23. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
[TBL] [Abstract][Full Text] [Related]
24. Autoimmunity in mice bearing lprcg: a novel mutant gene.
Kimura M; Matsuzawa A
Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845
[TBL] [Abstract][Full Text] [Related]
25. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
26. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
27. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand.
Ito MR; Terasaki S; Itoh J; Katoh H; Yonehara S; Nose M
Arthritis Rheum; 1997 Jun; 40(6):1054-63. PubMed ID: 9182916
[TBL] [Abstract][Full Text] [Related]
28. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
Fields ML; Sokol CL; Eaton-Bassiri A; Seo S; Madaio MP; Erikson J
J Immunol; 2001 Aug; 167(4):2370-8. PubMed ID: 11490027
[TBL] [Abstract][Full Text] [Related]
29. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
30. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
[TBL] [Abstract][Full Text] [Related]
31. Contribution of Fas ligand to cardiac allograft rejection.
Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
[TBL] [Abstract][Full Text] [Related]
32. Significant role for Fas in the pathogenesis of autoimmune diabetes.
Su X; Hu Q; Kristan JM; Costa C; Shen Y; Gero D; Matis LA; Wang Y
J Immunol; 2000 Mar; 164(5):2523-32. PubMed ID: 10679090
[TBL] [Abstract][Full Text] [Related]
33. Thymocyte apoptosis by T-2 toxin in vivo in mice is independent of Fas/Fas ligand system.
Murshedul AM; Nagase M; Yoshizawa T; Sakato N
Biosci Biotechnol Biochem; 2000 Jan; 64(1):210-3. PubMed ID: 10766511
[TBL] [Abstract][Full Text] [Related]
34. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
35. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.
Wei Y; Chen K; Sharp GC; Braley-Mullen H
J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889
[TBL] [Abstract][Full Text] [Related]
36. Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice.
Uchiyama H; Kishihara K; Minagawa R; Hashimoto K; Sugimachi K; Nomoto K
Immunology; 2002 Apr; 105(4):450-7. PubMed ID: 11985665
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells.
Rich RF; Green WR
J Virol; 1999 May; 73(5):3826-34. PubMed ID: 10196277
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice.
Kobata T; Takasaki K; Asahara H; Hong NM; Masuko-Hongo K; Kato T; Hirose S; Shirai T; Kayagaki N; Yagita H; Okumura K; Nishioka K
Immunology; 1997 Oct; 92(2):206-13. PubMed ID: 9415028
[TBL] [Abstract][Full Text] [Related]
39. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Takahashi T; Tanaka M; Brannan CI; Jenkins NA; Copeland NG; Suda T; Nagata S
Cell; 1994 Mar; 76(6):969-76. PubMed ID: 7511063
[TBL] [Abstract][Full Text] [Related]
40. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection.
Hsu HC; Zhang HG; Song GG; Xie J; Liu D; Yang PA; Fleck M; Wintersberger W; Zhou T; Edwards CK; Mountz JD
Arthritis Rheum; 2001 Sep; 44(9):2146-59. PubMed ID: 11592380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
